Top Markets
Coin of the day
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rank in Stocks #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Share Price
$0.3958979
Market Cap
$27.40M
Change (1 day)
-0.40%
Change (1 year)
-48.96%
Country
TW
Trade LAUNXP Biomedical Co., Ltd (6876)

Category

P/S ratio for LAUNXP Biomedical Co., Ltd (6876)
P/S ratio as of 2026 TTM: 0
According to LAUNXP Biomedical Co., Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for LAUNXP Biomedical Co., Ltd from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH